Abstract
The purpose of this study was to develop taste-masked oral disintegrating tablets (ODTs) using the combination of ion exchange resin and cyclodextrin, to mask the bitter taste and enhance drug dissolution. Meloxicam (MX) was selected as a model drug with poor water solubility and a bitter taste. Formulations containing various forms of MX (free drug, MX-loaded resin or resinate, complexes of MX and 2-hydroxypropyl-β-cyclodextrin (HPβCD) or MX/HPβCD complexes, and a mixture of resinate and MX/HPβCD complexes) were made and tablets were prepared by direct compression. The ODTs were evaluated for weight variation, thickness, diameter, hardness, friability, disintegration time, wetting time, MX content, MX release, degree of bitter taste, and stability. The results showed that thickness, diameter, weight, and friability did not differ significantly for all of these formulations. The tablet hardness was approximately 3 kg/in.2, and the friability was less than 1%. Tablets formulated with resinate and the mixture of resinate and MX/HPβCD complexes disintegrated rapidly within 60 s, which is the acceptable limit for ODTs. These results corresponded to the in vivo disintegration and wetting times. However, only tablets containing the mixture of resinate and MX/HPβCD complexes provided complete MX dissolution and successfully masked the bitter taste of MX. In addition, this tablet was stable at least 6 months. The results from this study suggest that the appropriate combination of ion exchange resin and cyclodextrin could be used in ODTs to mask the bitter taste of drug and enhance the dissolution of drugs that are weakly soluble in water.
Similar content being viewed by others
REFERENCES
Sastry SV, Nyshadham JR, Fıx JA. Recent technological advances in oral drug delivery—a review. Pharm Sci Technol Today. 2000;3(4):138–45.
Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Trop J Pharm Res. 2009;8:161–72.
Mohapatra A, Parikh RK, Gohel MC. Formulation, development and evaluation of patient friendly dosage forms of metformin, part—I: orally disintegrating tablets. Asian J Pharm. 2008;2:167–71.
Bhise K, Shaikh S, Bora D. Taste Mask, design and evaluation of an oral formulation using ion exchange resin as drug carrier. AAPS PharmSciTech. 2008;9(2):557–62.
Anand V, Kandarapu R, Garg S. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today. 2001;6:905–14.
Burke GM, Mendes RW, Jambhekar SS. Investigation of the application of ion exchange resins as a sustained release drug delivery system for propranolol hydrochloride. Drug Dev Ind Pharm. 1986;12:713–32.
Leea CW, Kima SJ, Youna YS, Widjojokusumoa E, Leea YH, Kimb J, et al. Preparation of bitter taste masked cetirizine dihydrochloride/β-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process. J Supercrit Fluid. 2010;5(1):348–57.
Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Advanced Drug Delivery Reviews. 2007;59:645–66.
Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci. 1996;85:1017–25.
The United State Pharmacopoeia XXXII/National FormulationXXVII. The United States Pharmacopoeial Convention. Rockville, MD; 2009.
Kunin R. Ion exchange resins. New York: Wiley; 1963.
Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm. 1997;158:29–38.
Samprasit W, Rojanarata T, Akkaramongkolporn P, Ngawhirunpat T, Sila-On W, Opanasopit P. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex. Drug Dev Ind Pharm. 2013. doi:10.3109/03639045.2012.729593.
Job P. Job’s plot analyses for the 2-CG and 3-CG complexes were consistent with 1:1 stoichiometry. Ann Chim. 1928;9:113–34.
Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci. 2009;98(11):3886–902.
Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech. 2004;36:1–6.
Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996;44:2121–7.
Luger P, Daneck K, Trummlitz WEG, Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci. 1996;4:175–87.
Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S. Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS PharmSciTech. 2004;5(4):1–8.
Sriwongjanya M, Bodmeier R. Entrapment of drug-loaded ion-exchange particles within polymeric microparticles. Int J Pharm. 1997;158:29–38.
Dowex product literature. http://www.dow.com. Accessed 26 Nov 2012.
Jeong SH, Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm. 2008;361:26–32.
Higuchi T, Kristiansen H. Binding specificities between small organic solutes in aqueous solutions: classification of some solutes onto two groups according to binding tendencies. J Pharm Sci. 1970;59:1601–8.
Obaidat AA, Khanfar RA, Khawam MN. The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling. J Incl Phenom Macrocycl Chem. 2009;63:273–9.
Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences. London: Lippincott Williams & Wilkins; 2011. p. 197–222.
Jug M, Bećirević-Laćan M. Influence of hydroxypropyl-β-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci. 2004;21:251–60.
Sheshala R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res. 2011;34(11):1945–56.
Fenyresi E, Shirankura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull. 1984;32:665–9.
Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and β-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech. 2004;5(4):1–6.
Rudnic EM, Rhodes CT, Welsh S, Bernardo P. Evaluation of the mechanism of disintegrant action. Drug Dev Ind Pharm. 1982;8:87–109.
Amberlite product literature. http://www.rohmhaas.com. Accessed 26 Nov 2012.
Akkaramongkolporn P, Ngawhirunpat T, Nunthanid J, Opanasopit P. Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers. AAPS PharmSciTech. 2008;9(3):899–908.
Sriwongjanya M, Bodmeier R. Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm. 1998;46:321–7.
Pattarakan N, Opanasopit P, Ngawhirunpat T, Akkaramongkolporn P. Application of ion exchange resins as tablet disintegrants. The 26th Annual Research Conference in Pharmaceutical Science. 04 December 2009. Bangkok, Thailand.
Kornblum SS, Stoopak SB. A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone. J Pharm Sci. 1973;62(1):43–9.
Jivraj M, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Tech Today. 2000;3:58–62.
Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull. 2004;52(6):704–7.
Bi Y, Hisakadzu S. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996;44:2121–7.
Fenyresi E, Shirankura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull. 1984;32:665–9.
Jinichi F, Etsuo Y, Yasuo Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm. 2006;310:101–9.
Akkaramongkolporn P, Yononemochi E, Terada K. Molecular state of chlorpheniramine in resinates. Chem Pharm Bull. 2000;48(2):231–4.
Dahiya S, Pathak K. Influence of amorphous cyclodextrin derivatives on aceclofenae release from directly compressible tablets. Pharmazie. 2007;62:278–83.
ACKNOWLEDGMENTS
The authors wish to thank the Commission of Higher Education (Thailand), the Thailand Research Funds through the Golden Jubilee PhD Program (Grant No. PHD/0001/2553) and the Silpakorn University Research and Development Institute for financial support (Grant No. SURDI 55/02/2555).
Author information
Authors and Affiliations
Corresponding author
Additional information
This article was retracted at the request of the authors because of an error in data compilation.
About this article
Cite this article
Samprasit, W., Akkaramongkolporn, P., Ngawhirunpat, T. et al. RETRACTED ARTICLE: Meloxicam Taste-Masked Oral Disintegrating Tablet with Dissolution Enhanced by Ion Exchange Resins and Cyclodextrin. AAPS PharmSciTech 14, 1118–1128 (2013). https://doi.org/10.1208/s12249-013-0001-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-013-0001-y